✦ LIBER ✦

Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States

✍ Scribed by Ferreira, A.; Sagkriotis, A.; Milnes, F.; Olson, M.; Hill, J.; Lu, J.; Makin, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of wet age-related macular deg

✍ M.A. Muriel; B. Fatela; A. Valdivia; F. Clement 📂 Article 📅 2011 🏛 Elsevier ⚖ 716 KB

Cost and Effectiveness of Therapy for We

✍ Studnicka, Jan; Ríhová, Barbora; Rencová, Eva; Rozsíval, Pavel; Dubská, Zora; Ch 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 114 KB

Initial experience with aflibercept in t

✍ Cervera, R.E.; Castro, V.; Montero, J.; Torralba, C.; Gracia, A. 📂 Article 📅 2014 🏛 Elsevier ⚖ 387 KB

Efficacy of treatment with ranibizumab i

✍ Wolf, Armin; Kampik, Anselm 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 367 KB

Aflibercept in Neovascular (Wet) Age-Rel

✍ Brown, A.; Ferreira, A.; Lamle, S.; Milnes, F. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Ranibizumab and verteporfin photodynamic

✍ Shital Mani 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 136 KB